Graeme Clark Collection

Permanent URI for this collection

Search Results

Now showing 1 - 8 of 8
  • Item
    Thumbnail Image
    The histopathology of the human temporal bone and auditory central nervous system following cochlear implantation in a patient: correlation with psychophysics and speech perception results
    Clark, Graeme M. ; Shepherd, Robert K. ; Franz, Burkhard K.-H. ; Dowell, Richard C. ; Tong, Yit C. ; Blamey, Peter J. ; Webb, Robert L. ; Pyman, Brian C. ; McNaughton, Judy ; Bloom, David M. ; Kakulas, Byron A. ; Siejka, Stan ( 1988)
    Cochlear implantation has become a recognised surgical procedure for the management of a profound-total hearing loss, especially in patients who have previously had hearing before going deaf (postlingual deafness). Nevertheless, it is important for progress in the field that patients who have had a cochlear implant, bequeath their temporal bones for research. This will then make it possible to further assess the safety of the procedure, and the factors that are important for its effectiveness. Biological safety has been assessed in a number of studies on animals, in particular, the biocompatibility of the materials used (1,2), the histopathological effects of long-term implantation on the cochlea (3, 4, 5, 6, 7, 8), and the effects of chronic electrical stimulation on the viability of spiral ganglion cells (9, 10, 11, 12). In studying the temporal bones of deceased cochlear implant patients it is possible to help establish that the animal experimental results are applicable to Man. Surgical trauma has been most frequently evaluated by inserting electrodes into cadaver temporal bones. It is important, however, to examine bones that have been previously implanted surgically to ensure that the cadaver findings are applicable to operations on patients. The effectiveness of cochlear implantation can be studied by correlating the histopathological findings, the dendrite and spiral ganglion cell densities, in particular, with the psychophysical and speech perception results. Other benefits also accrue, for example, establishing the accuracy of preoperative X-rays and electrical stimulation of the promontory in predicting cochlear pathology and spiral ganglion cell numbers. For the above reasons it has been especially interesting to examine both the temporal bones and central nervous system from one of our patients (patient 13) who participated in the initial clinical trial of the Cochlear Proprietary Limited (a member of the Nucleus group) multiple-electrode cochlear prosthesis, and who died due to a myocardial infarction following coronary bypass surgery.
  • Item
    Thumbnail Image
    The University of Melbourne/Nucleus cochlear prosthesis
    Clark, Graeme M. ; Blamey, P. J. ; Brown, A. M. ; Busby, P. A. ; Dowell, R. C. ; Franz, B. K-H. ; Millar, J. B. ; Pyman, B. C. ; Shepherd, R. K. ; Tong, Y. C. ; Webb, R. L. ; Brimacombe, J. A. ; Hirshorn, M. S. ; Kuzma, J. ; Mecklenburg, D. J. ; Money, D. K. ; Patrick, J. F. ; Seligman, P. M. ( 1988)
    This is a review of research to develop the University of Melbourne/Nucleus cochlear prosthesis for patients with a profound-total hearing loss. A more complete review can be obtained in Clark et al. A prototype receiver-stimulator and multiple-electrode array developed at the University of Melbourne was first implanted in a postlingually deaf adult patient with a profound-total hearing loss on 1 August 1978. A speech processing strategy which could help this patient understand running speech, especially when combined with lipreading was developed in 1978 following initial psychophysical studies. A prototype wearable speech processor was fabricated in 1979, that could provide significant help for the first two patients in understanding running speech when used in combination with lipreading compared with lipreading alone, and it also enabled them to understand some running speech when using electrical stimulation alone. An implantable receiver-stimulator and wearable speech processor embodying the principles of the prototype devices were then produced for clinical trial by the Australian biomedical firm, Nucleus Ltd, and its subsidiaries, Cochlear Pty Ltd and Cochlear Corporation. This cochlear implant was initially clinically trialled on six patients at The Royal Victorian Eye & Ear Hospital in 1982, and shown to give similar results to those obtained with the prototype device. In view of these findings a clinical trial was carried out for a Premarket Approval Application to the US Food and Drug Administration (FDA), and extended to a number of centres in the US, Canada, and West Germany. This clinical trial confirmed that patients could understand running speech when electrical stimulation was combined with lipreading, and that some patients could also understand running speech when using electrical stimulation alone. Today, more than 600 patients world-wide are using cochlear implants developed from the research described in this paper.
  • Item
    Thumbnail Image
    Preliminary results for the Cochlear Corporation multielectrode intracochlear implant in six prelingually deaf patients
    Clark, Graeme M. ; Busby, Peter A. ; Roberts, Susan A. ; Dowell, Richard C. ; Blamey, Peter J. ; Mecklenburg, Dianne J. ; Webb, Robert L. ; Pyman, Brian C. ; Franz, Burkhard K. ( 1987)
    The preliminary results from this study indicate that some prelingually deaf patients may get worthwhile help from a multiple-electrode cochlear implant that uses a formant-based speech processing strategy. It is encouraging that these improvements can occur in young adults and teenagers. The results for two children are also encouraging. A 10-year-old child obtained significant improvement on some speech perception tests. It was easy to set thresholds and comfortable listening levels on a 5-year-old child, and he is now a regular user of the device. There are, however, considerable variations in performance among the prelingual patients, which may be related to the following factors: whether they have had some hearing after birth, the method of education used, the motivation of the patient, and age at implantation.
  • Item
    Thumbnail Image
    A multiple-electrode intracochlear implant for children
    Clark, Graeme M. ; Blamey, Peter J. ; Busby, Peter A. ; Dowell, Richard C. ; Franz, Burkhard K-H. ; Musgrave, Gaye Nicholls ; Nienhuys, Terry G. ; Pyman, Brian C. ; Roberts, Susan A. ; Tong, Yit C. ; Webb, Robert L. ; Kuzma, Januz A. ; Money, David K. ; Patrick, James F. ; Seligman, Peter M. ( 1987)
    A multiple-electrode intracochlear implant that provides 21 stimulus channels has been designed for use in young children. It is smaller than the adult version and has magnets to facilitate the attachment of the headset. It has been implanted in two children aged 5 and 10 years. The two children both lost hearing in their third year, when they were still learning language. Following implantation, it was possible to determine threshold and comfortable listening levels for each electrode pair. This was facilitated in the younger child by prior training in scaling visual and electrotactile stimuli. Both children are regular users of the implant, and a training and assessment program has been commenced.
  • Item
    Thumbnail Image
    The multi-channel cochlear implant
    Webb, R. L. ; Dowell, R. C. ; Clark, Graeme M. ; Pyman, A. M. ; Brown, Y. C. ; Tong, Y. C.. ; Seligman, P. M. ; Blamey, P.J. ; Xu, S. ( 1984/85)
    The multi-channel cochlear implant codes sounds on the bases of rate and place pitch. Experimental studies on animals and patients have shown it is difficult for electrical stimulation to code rate pitch above about 200-400 pulses/second. Therefore to convey as much information about speech as possible it is necessary to produce multi-channel stimulation or place pitch so that the important frequency cues in vowels and consonants can be perceived by the patient.
  • Item
    Thumbnail Image
    Clinical trial of a multi-channel cochlear prosthesis: results on 10 postlingually deaf patients
    Clark, Graeme M. ; Dowell, R. C. ; Pyman, B. C. ; Brown, A. M. ; Webb, R. L. ; Tong, Y. C. ; Bailey, Q. ; Seligman, P. M. ( 1984)
    The clinical trial of a multi-channel cochlear prosthesis has been carried out on 10 profoundly-totally deaf adult patients. Speech perception tests have shown that all the patients received significant benefit from the device. They obtained improvements in understanding running speech from 47% to 550% when using the device in conjunction with lipreading compared to lipreading alone. With an open-set CID sentence test, three patients obtained scores showing an ability to understand speech without the need to lipread, and a further three patients had scores indicating they could also receive useful information without lipreading. In two patients, very limited open-set scores for electrical stimulation alone were obtained. This was most probably due to the fact that only a few channels of stimulation were possible due to cochlear disease and they were therefore receiving information more like a single-channel device. The prosthesis has also been found to provide considerable help in hearing and recognizing everyday sounds.
  • Item
    Thumbnail Image
    The clinical trial of a multi-channel cochlear prosthesis
    Pyman, B. C. ; Clark, Graeme M. ; Dowell, R. C. ; Webb, R. L. ; Brown, A. M. ; Bailey, Q. E. ; Luscombe, S. M. ( 1983)
    The results of a multiple-electrode cochlear implant carried out on 1st August, 1978 on a totally deaf patient (post-lingual hearing loss) showed that he could perceive sounds of different pitches depending on the electrode stimulated, and this finding was consistent with the place theory of frequency coding. Furthermore, stimulating individual electrodes produced percepts which the patient described as vowel-like in quality. The patient could also perceive different pitches which varied with the rate of stimulation up to 200 pulses/second, but at higher rates he had difficulties perceiving pitch changes (Clark et al. 1978; Tong et al, 1979). As a result of the psychophysical studies a speech processor was developed. The speech processor extracted: firstly, the voicing frequency to help the patient hear the rhythm of speech and know whether a speech sound was voiced or unvoiced (e.g., /b/ versus /p/); and, secondly, the second formant to enable the patient to recognize vowels and consonants and so hear words. In order to maximize speech intelligibility, the second formant stimulated an appropriate electrode, and the rate of stimulation on that electrode was related to the voicing frequency.
  • Item
    Thumbnail Image
    Selection of patients for multiple-channel cochlear implantation
    Brown, A. M. ; Dowell, R. C. ; Clark, Graeme M. ; Martin, L. F. A. ; Pyman, B. C. (Raven Press, 1985)
    Only profoundly, bilaterally deaf adults are considered for evaluation. It is necessary to determine that the patient's communication ability cannot be improved to any significant degree with conventional hearing aids currently available. Initial assessment consists of audiometry, hearing aid evaluation(s), otological and medical examination, and for patients with no recent experience with hearing aids, a hearing aid trial. Polytome x-rays of temporal bones is carried out to ensure that cochlea structures are not grossly abnormal. Electrical stimulation of the promontory is used to confirm the presence of residual auditory nerve fibers. Where there is an audiometric difference between ears, the poorer ear is chosen for implantation provided there are no other contraindications. Intensive counselling is carried out to enable patients to make a fully informed decision about implantation. Patients undergo a battery of speech discrimination and lipreading tests with their hearing aid after their hearing aid trial. This is to provide a baseline for comparison with postoperative results and to assess the benefit obtained from the hearing aid. Any significant improvement in test results when using a hearing aid over lipreading alone would be a contraindication for implantation. Medical assessment is carried out as for any major surgery, including pathology, respiratory function tests and cardiovascular assessment. Particular emphasis is placed on infection prevention immediately preoperatively and during surgery.